top of page
Search
  • Writer's pictureARQon
    • Jul 4, 2018
    • 1 min read

SFDA with New Medical Device Marketing Authorization (MDMA) and Fast Track Fee


The Saudi Food and Drug Authority (SFDA) informs medical devices manufacturers and their Authorized Representatives that Marketing Authorization fess (MDMA) has been updated according to the table below:

Notes:

  • New fees take into account number of products in the application regardless of devices risk classification.

  • Devices accessories are counted within the number of products

  • Application shall comply with SFDA criteria of Bundled devices.

SFDA is also introducing Fast track service. This new propose fees will be in place soon.

Contact us at info@arqon.com.


208 views0 comments

Recent Posts

See All

Asia, Africa & Middle East - Aug 2019

Australia: 2019 fees and charges released by the Therapeutic Goods Administration Australia: Conformity assessment standards for medical device QMSs Australia: TGA will no longer send out annual repor

Asia, Africa & Middle East - Dec 2018

AHWP: Guidance on labelling for in vitro diagnostic medical devices Australia: Application fee change for export only medical devices Australia: Updated requirements specified for preliminary assessme

bottom of page